Clinical Trials Directory

Trials / Sponsors / Evelo Biosciences, Inc.

Evelo Biosciences, Inc.

Industry · 10 registered clinical trials.

StatusTrialPhaseStarted
CompletedEvaluation of the Immunopharmacology of EDP1815 and EDP2939
KLH and Imiquimod Induced Skin Inflammation in Healthy Volunteers
Phase 12022-06-27
TerminatedA Long-Term Extension Trial in Participants With Atopic Dermatitis Who Participated in Previous EDP1815 Trials
Atopic Dermatitis
Phase 22022-06-06
CompletedA Study Investigating the Effect of EDP1815 in the Treatment of Mild, Moderate and Severe Atopic Dermatitis
Atopic Dermatitis
Phase 22022-01-31
CompletedScintigraphy Study to Evaluate the Gastrointestinal Behavior of EDP1815 Oral Dosage Forms
Disintegration, Healthy
Phase 12021-08-09
CompletedStudy in Healthy Participants and Participants With Moderate Atopic Dermatitis & Optionally, Moderate Psoriasi
Atopic Dermatitis, Psoriasis, Asthma
Phase 12021-02-23
CompletedA Phase 2 Study Investigating the Effect of EDP1815 in the Treatment of Mild to Moderate Plaque Psoriasis
Psoriasis, Plaque Psoriasis
Phase 22020-09-21
TerminatedSafety and Efficacy of EDP1815 in the Treatment of Patients Hospitalized With COVID-19 Infection
Covid19
Phase 22020-08-26
CompletedA Study of EDP1066 in Healthy Participants and Participants With Mild to Moderate Psoriasis and Atopic Dermati
Psoriasis, Atopic Dermatitis
Phase 12019-04-24
CompletedA Study of EDP1503 in Patients With Colorectal Cancer, Breast Cancer, and Checkpoint Inhibitor Relapsed Tumors
Colorectal Cancer Metastatic, Triple Negative Breast Cancer, Non Small Cell Lung Cancer
Phase 12018-12-19
CompletedA Study of EDP1815 in Healthy Participants and Participants With Mild to Moderate Psoriasis and Atopic Dermati
Psoriasis, Atopic Dermatitis
Phase 12018-11-19